It has been shown that Kras (G12D) plays an important role in controlling pancreatic cancer metabolism by stimulating glucose uptake and directing glucose intermediates into hexosamine biosynthesis and the pentose phosphate pathway (PPP). This evidence concerns the gene KRAS and familial pancreatic carcinoma.